Edgewise Therapeutics raises $95M to fund muscular-dystrophy drug trials
BOULDER — Edgewise Therapeutics Inc. has more than doubled its previous fundraising rounds by closing a $95 million Series C […]
Source: BizWest
Check out market updates
BOULDER — Edgewise Therapeutics Inc. has more than doubled its previous fundraising rounds by closing a $95 million Series C […]
Source: BizWest